Introduction, learning objectives and revision of training material G.B. Migliori (Tradate, Italy)
| |
Results of the FP7 TB PAN-NET EU funded project V. Katalinic (Zaghreb, Crotia)
| |
Filling the global training gap L. D' Ambrosio (Tradate, Italy)
| |
TB elimination: theory and practice in Europe G.B. Migliori (Tradate, Italy)
| |
Defining or redefining TB Elimination. ‘Fast’ Food for Thought D. Manissero (Geneva, Switzerland)
| |
The US experience L. Reichman (New Jersey, USA)
| |
Perspectives on the new drugs pipeline L. Reichman (New Jersey, USA)
| |
News on treatment of LTBI I. Abubakar (London, UK)
| |
General principles G. Sotgiu (Sassari, Italy)
| |
Trials for TB infection and disease drugs: special aspects I. Abubakar (London, UK)
| |
Trials for TB infection and disease drugs: special aspects J-P. Zellweger (Fribourg, Switzerland)
| |
Trials for TB infection diagnostics: designing a protocol D. Cirillo (Milan, Italy)
| |
Trials for TB disease diagnostics: designing a protocol V. Katalinic (Zaghreb, Crotia)
| |
New guidelines to manage MDR-TB M. Dara (Geneva, Switzerland)
| |
A Phase III Study of a New Inhaled Therapy for MDR TB - Ficticionid Participants presentation
| |
LTBI Protocol Participants presentation
| |
Research priorities for TB elimination low prevalence countries Participants presentation
| |
Country A Participants presentation
| |
Country B Participants presentation
| |
Country B Presentation Participants presentation
| |